E.B. Solomont
By E.B. Solomont
-
Culture Chabad Makes Major Inroads at Universities
Toward the end of the spring semester this past May, a Chabad-Lubavitch rabbi and about a dozen students celebrated a major victory at Tufts University. After nearly two years of vying for recognition as an official student group at the liberal arts college in Medford, Mass., Tufts’s student government finally recognized Chabad. Rabbi Tzvi Backman…
-
Israel News Judd’s Interfaith Show Nixed
Interfaith marriage is not the taboo it used to be in the Jewish community, but the topic is stirring controversy on cable television. Early in the week, the producer of a new talk show, to be hosted on the Hallmark Channel by legendary country singer Naomi Judd, was soliciting participants for a segment on interfaith…
-
News Rightist’s Blast On Stem Cells Stirs Outrage
After a leading religious conservative leader compared stem-cell research to Nazi medical experiments, several groups that condemned the analogy have reported a flood of messages from angry protesters, some of them threatening violence. During his syndicated radio show August 3, James Dobson, one of the country’s most influential religious conservatives and chairman of the conservative…
-
News Frist Hailed on Stem Cells
Erstwhile Christian conservatives are criticizing Senate Majority Leader Bill Frist for endorsing a bill that would expand federal support for stem-cell research, but Jewish organizations are hailing the Tennessee Republican. Frist’s decision — outlined in a lengthy July 29 speech on the Senate floor — came as a surprise to the bill’s supporters, who had…
-
Culture Cord Blood Transplants Eyed As Therapy for Some Diseases
In a medical development with potentially far-reaching effects, researchers have transplanted cord blood into newborns with a rare genetic disease, preserving their brain development and performing a life-saving treatment for babies with a fatal genetic disorder. Scientists from Duke University Medical Center and the University of North Carolina at Chapel Hill, infused cord blood stem…
-
Culture Supplements Holding Hope As Treatment For Canavan
New research indicates that acetate supplements may be an effective therapy for Canavan disease, a degenerative and ultimately fatal disorder of the brain and central nervous system. Currently, there is no cure for Canavan disease, a recessive genetic disorder that is carried by one in 40 Ashkenazic Jews. Canavan patients have a mutation of the…
-
News Noted Patisserie Ventures Into Kosher Realm
Since opening its doors eight years ago, New York’s Payard Patisserie & Bistro has been known for its upscale clientele, Parisian décor and heavenly pastries. But for the last couple of months, Payard has had one more thing to its credit: kosher options. Since the spring, the shop has offered a small selection of kosher…
-
Israel News Columnist: No ‘Easy’ Answer
This week Randy Cohen, known as “The Ethicist” in the pages of The New York Times Magazine, showed that when it comes to Jewish sensibilities, he is an equal opportunity offender. First, in October 2002, Cohen upset Orthodox readers when he advised a letter writer to tear up a contract with an Orthodox male real…
Explore
Most Popular
- 1
Opinion Hamas made a remarkable offer — because Trump laid a remarkable trap
- 2
News Hundreds of Northwestern students can’t register for class because they won’t watch an antisemitism training video. Here’s what’s in it.
- 3
Fast Forward Hegseth says ‘no more beardos’ in the military. What about religious exemptions?
- 4
Opinion A Yom Kippur confessional for 2025
In Case You Missed It
-
Opinion I’m Israeli. She’s Palestinian. There’s a devastatingly simple reason why we’ve bonded during this war
-
Opinion Hamas made a remarkable offer — because Trump laid a remarkable trap
-
Fast Forward Hamas says it’s ready to release all Israeli hostages but does not offer clear ‘yes’ to Trump’s plan
-
Fast Forward In Saudi Arabia, Dave Chappelle jokes that ‘I stand with Israel’ would be his code for censorship
-
Shop the Forward Store
100% of profits support our journalism
